Research output per year
Research output per year
Fingerprint
The fingerprint consists of automatically generated concepts related to the associated persons. It is updated automatically, when new content is added.
- 1 Similar Profiles
Collaborations from the last five years
Dive into details by clicking on the dots.
Research output
-
PSMA PET/CT improves overall survival in men with biochemical recurrent prostate cancer who are treated with salvage radiotherapy; A national cohort study
Mogensen, A., Torp-Pedersen, C., Nørgaard, M., Petersen, L., Kempel, M. & Zacho, H., Sept 2024, In: European Journal of Nuclear Medicine and Molecular Imaging. 51, Suppl. 1, p. S197-S198 2 p., OP-429.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Safety Analyses of the Phase 3 VISION Trial of [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
Chi, K. N., Armstrong, A. J., Krause, B. J., Herrmann, K., Rahbar, K., de Bono, J. S., Adra, N., Garje, R., Michalski, J. M., Kempel, M. M., Fizazi, K., Morris, M. J., Sartor, O., Brackman, M., DeSilvio, M., Wilke, C., Holder, G. & Tagawa, S. T., Apr 2024, In: European Urology. 85, 4, p. 382-391 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile9 Citations (Scopus)26 Downloads (Pure) -
A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients
Petersen, S. E., Thorsen, L. B., Hansen, S., Petersen, P. M., Lindberg, H., Moe, M., Petersen, J. B., Muren, L. P., Høyer, M. & Bentzen, L., 2022, In: Acta Oncologica. 61, 2, p. 179-184 6 p.Research output: Contribution to journal › Conference article in Journal › Research › peer-review
8 Citations (Scopus) -
Exposure-adjusted safety analyses of the VISION phase 3 trial of 177 Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
Chi, K. N., Adra, N., Garje, R., Michalski, J. M., Lavalaye, J., Kempel, M. M., Brackman, M., Perraud, K., Holder, G. & Armstrong, A. J., 2022, In: Journal of Clinical Oncology. 40, Suppl. 6, p. 85Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
-
Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen
Holmsten, K., Omland, L. H., Als, A. B., Agerbæk, M., Dohn, L. H., Lindberg, H., Jensen, N. V., Carus, A., Moe, M., Hosseini, A., Radkiewicz, C., Pappot, H. & Ullén, A., Mar 2022, In: Bladder Cancer. 8, 1, p. 71-80 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile5 Citations (Scopus)43 Downloads (Pure)
Datasets
-
A phase I/II study of acute and late physician assessed and patient-reported morbidity following whole pelvic radiation in high-risk prostate cancer patients
Petersen, S. E. (Creator), Thorsen, L. B. (Creator), Hansen, S. (Creator), Petersen, P. M. (Creator), Lindberg, H. (Creator), Moe, M. (Creator), Petersen, J. B. (Creator), Muren, L. P. (Creator), Høyer, M. (Creator) & Bentzen, L. (Creator), Taylor & Francis, 20 Sept 2021
DOI: 10.6084/m9.figshare.16646013.v1, https://tandf.figshare.com/articles/dataset/A_phase_I_II_study_of_acute_and_late_physician_assessed_and_patient-reported_morbidity_following_whole_pelvic_radiation_in_high-risk_prostate_cancer_patients/16646013/1
Dataset